COGZF (Cogstate) Beta: 0.4371 (As of Jun. 24, 2026)


COGZF Cogstate Ltd COGZF
90 GF Score
Price $1.89
GF Value $1.57
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cogstate Beta?

Cogstate COGZF 90 Beta is 0.4371 as of Jun. 24, 2026. GuruFocus rates COGZF with a GF Score™ of 90/100 and a GF Value™ of $1.57 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Cogstate's Beta is 0.4371.


Cogstate  (OTCPK:COGZF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cogstate Beta Related Terms


Cogstate Beta Historical Data

* Premium members only.

The historical data trend for Cogstate's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogstate Beta Chart

Cogstate Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 1.24 0.55 0.14 -0.08

Cogstate Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.14 0.13 -0.08 0.35

COGZF vs VEEV, BTSG, TEM: Beta Comparison

For the Health Information Services subindustry, Cogstate's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cogstate Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's Beta distribution charts can be found below:

* The bar in red indicates where Cogstate's Beta falls into.


COGZF
90GF Score
Cogstate Ltd COGZF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogstate Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.4371 mean?
Cogstate (COGZF) has a Beta of 0.4371 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cogstate and its competitors.
Is Cogstate's Beta too high?
Cogstate's current Beta is 0.4371. Overall, Cogstate has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's Beta compare to VEEV and BTSG?
Cogstate's Beta of 0.4371 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cogstate and its competitors. Cogstate's current Beta is 0.4371. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (COGZF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.57, compared to a current price of $1.89 — trading 20.4% above its estimated fair value. The current Beta is 0.4371. Cogstate's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Cogstate (COGZF), the current Beta is 0.4371 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cogstate (COGZF) Overvalued in 2026?

Based on GuruFocus' analysis, Cogstate stock appears to be overvalued. The current stock price of $1.89 is trading 20.4% above its estimated GF Value™ of $1.57. GuruFocus considers Cogstate to be Modestly Overvalued.

Key valuation signals for COGZF:

  • Beta: 0.4371
  • GF Value™: $1.57 vs. price of $1.89 (20.4% above fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the COGZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cogstate Business Description

Other Exchanges C4B:GermanyCGS:Australia
Address 367 Collins Street, Level 32, Melbourne, VIC, AUS, 3000
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
90GF Score

Get the complete analysis for COGZF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.89
Price
$1.57
GF Value